These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11850784)
1. Telomere dysfunction: multiple paths to the same end. Harrington L; Robinson MO Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784 [TBL] [Abstract][Full Text] [Related]
2. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Artandi SE; Attardi LD Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944 [TBL] [Abstract][Full Text] [Related]
3. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. Lee MK; Hande MP; Sabapathy K J Cell Sci; 2005 Feb; 118(Pt 4):819-29. PubMed ID: 15687103 [TBL] [Abstract][Full Text] [Related]
4. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Rudolph KL; Millard M; Bosenberg MW; DePinho RA Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263 [TBL] [Abstract][Full Text] [Related]
5. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Farazi PA; Glickman J; Horner J; Depinho RA Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430 [TBL] [Abstract][Full Text] [Related]
6. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models. Attardi LD Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53. Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373 [TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells. Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938 [TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction. Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690 [TBL] [Abstract][Full Text] [Related]
11. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Farazi PA; Glickman J; Jiang S; Yu A; Rudolph KL; DePinho RA Cancer Res; 2003 Aug; 63(16):5021-7. PubMed ID: 12941829 [TBL] [Abstract][Full Text] [Related]
13. Senescence and immortalization: role of telomeres and telomerase. Shay JW; Wright WE Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900 [TBL] [Abstract][Full Text] [Related]
14. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice. Sgura A; De Amicis A; Stronati L; Cinelli S; Pacchierotti F; Tanzarella C Environ Mol Mutagen; 2008 Jul; 49(6):467-75. PubMed ID: 18481314 [TBL] [Abstract][Full Text] [Related]
15. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Gu J; Spitz MR; Zhao H; Lin J; Grossman HB; Dinney CP; Wu X Carcinogenesis; 2005 Oct; 26(10):1741-7. PubMed ID: 15905204 [TBL] [Abstract][Full Text] [Related]
16. TERT regulates cell survival independent of telomerase enzymatic activity. Cao Y; Li H; Deb S; Liu JP Oncogene; 2002 May; 21(20):3130-8. PubMed ID: 12082628 [TBL] [Abstract][Full Text] [Related]
17. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Hackett JA; Greider CW Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787 [TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation. Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891 [TBL] [Abstract][Full Text] [Related]
19. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Lee KH; Rudolph KL; Ju YJ; Greenberg RA; Cannizzaro L; Chin L; Weiler SR; DePinho RA Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3381-6. PubMed ID: 11248087 [TBL] [Abstract][Full Text] [Related]
20. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Goldkorn A; Blackburn EH Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]